PubMed:26033938 / 453-927 JSONTXT

{"project":"Glycan-Motif","denotations":[{"id":"T1","span":{"begin":237,"end":246},"obj":"https://glytoucan.org/Structures/Glycans/G71832QJ"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":237,"end":246},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G71832QJ"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T4","span":{"begin":0,"end":474},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":474},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":474},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":237,"end":246},"obj":"https://glytoucan.org/Structures/Glycans/G71832QJ"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":225,"end":230},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"T2","span":{"begin":225,"end":230},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T9","span":{"begin":51,"end":63},"obj":"FMAID:82737"},{"id":"_T10","span":{"begin":51,"end":63},"obj":"FMAID:197276"},{"id":"_T11","span":{"begin":64,"end":74},"obj":"FMAID:167180"},{"id":"_T12","span":{"begin":167,"end":180},"obj":"FMAID:167256"},{"id":"_T13","span":{"begin":167,"end":180},"obj":"FMAID:62925"},{"id":"_T14","span":{"begin":209,"end":220},"obj":"FMAID:196773"},{"id":"_T15","span":{"begin":209,"end":220},"obj":"FMAID:82780"},{"id":"_T16","span":{"begin":225,"end":230},"obj":"FMAID:256053"},{"id":"_T17","span":{"begin":253,"end":261},"obj":"FMAID:214710"},{"id":"_T18","span":{"begin":284,"end":303},"obj":"FMAID:196779"},{"id":"_T19","span":{"begin":284,"end":303},"obj":"FMAID:196735"},{"id":"_T20","span":{"begin":284,"end":303},"obj":"FMAID:82785"},{"id":"_T21","span":{"begin":284,"end":303},"obj":"FMAID:82746"},{"id":"_T22","span":{"begin":330,"end":345},"obj":"FMAID:82785"},{"id":"_T23","span":{"begin":330,"end":345},"obj":"FMAID:82746"},{"id":"_T24","span":{"begin":330,"end":345},"obj":"FMAID:196735"},{"id":"_T25","span":{"begin":330,"end":345},"obj":"FMAID:196779"},{"id":"_T26","span":{"begin":350,"end":366},"obj":"FMAID:82742"},{"id":"_T27","span":{"begin":350,"end":366},"obj":"FMAID:196731"},{"id":"_T28","span":{"begin":389,"end":399},"obj":"FMAID:167180"},{"id":"_T29","span":{"begin":454,"end":473},"obj":"FMAID:82746"},{"id":"_T30","span":{"begin":454,"end":473},"obj":"FMAID:196735"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":183,"end":185},"obj":"http://www.uniprot.org/uniprot/Q8SNA0"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"uniprot-mouse","denotations":[{"id":"T1","span":{"begin":183,"end":185},"obj":"http://www.uniprot.org/uniprot/P04441"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T8","span":{"begin":231,"end":236},"obj":"http://purl.bioontology.org/ontology/STY/T096"},{"id":"T9","span":{"begin":380,"end":385},"obj":"http://purl.bioontology.org/ontology/STY/T096"},{"id":"T10","span":{"begin":418,"end":427},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/809"},{"id":"T11","span":{"begin":418,"end":427},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/51291"},{"id":"T12","span":{"begin":418,"end":427},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/204428"},{"id":"T13","span":{"begin":418,"end":427},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/810"},{"id":"T14","span":{"begin":418,"end":427},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/204429"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"GO-MF","denotations":[{"id":"T3","span":{"begin":64,"end":74},"obj":"http://purl.obolibrary.org/obo/GO_0003823"},{"id":"T4","span":{"begin":389,"end":399},"obj":"http://purl.obolibrary.org/obo/GO_0003823"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"UBERON-AE","denotations":[{"id":"T1","span":{"begin":225,"end":230},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T1","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G91657BL\""},{"id":"GlycanIUPAC_T2","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G07870IV\""},{"id":"GlycanIUPAC_T3","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G41755UM\""},{"id":"GlycanIUPAC_T4","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G51694HC\""},{"id":"GlycanIUPAC_T5","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G41024ZB\""},{"id":"GlycanIUPAC_T6","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G56493GV\""},{"id":"GlycanIUPAC_T7","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G67732AD\""},{"id":"GlycanIUPAC_T8","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G71637HZ\""},{"id":"GlycanIUPAC_T9","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G32728TD\""},{"id":"GlycanIUPAC_T10","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G53466WL\""},{"id":"GlycanIUPAC_T11","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G66924NS\""},{"id":"GlycanIUPAC_T12","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G75457JH\""},{"id":"GlycanIUPAC_T13","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G71084AX\""},{"id":"GlycanIUPAC_T14","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G07386WM\""},{"id":"GlycanIUPAC_T15","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G43975HS\""},{"id":"GlycanIUPAC_T16","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G18466CA\""},{"id":"GlycanIUPAC_T17","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G08131SX\""},{"id":"GlycanIUPAC_T18","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G88685HF\""},{"id":"GlycanIUPAC_T19","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G92956PT\""},{"id":"GlycanIUPAC_T20","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G98826MO\""},{"id":"GlycanIUPAC_T21","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G95216FL\""},{"id":"GlycanIUPAC_T22","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G83786ZO\""},{"id":"GlycanIUPAC_T23","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G43896QJ\""},{"id":"GlycanIUPAC_T24","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G76250TH\""},{"id":"GlycanIUPAC_T25","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G99652IU\""},{"id":"GlycanIUPAC_T26","span":{"begin":403,"end":406},"obj":"\"http://rdf.glycoinfo.org/glycan/G78740SJ\""}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"GlycoBiology-MAT","denotations":[{"id":"T1","span":{"begin":225,"end":230},"obj":"http://purl.obolibrary.org/obo/MAT_0000315"},{"id":"T2","span":{"begin":225,"end":230},"obj":"http://purl.obolibrary.org/obo/MAT_0000083"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"GlycoBiology-Motifs","denotations":[{"id":"T1","span":{"begin":225,"end":236},"obj":"http://rdf.glycoinfo.org/glycan/G00066MO"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":225,"end":230},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"mondo_disease","denotations":[{"id":"T4","span":{"begin":187,"end":192},"obj":"Disease"},{"id":"T5","span":{"begin":418,"end":427},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005701"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"NCBITAXON","denotations":[{"id":"T2","span":{"begin":418,"end":427},"obj":"OrganismTaxon"}],"attributes":[{"id":"A2","pred":"db_id","subj":"T2","obj":"810"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":153,"end":159},"obj":"Body_part"},{"id":"T2","span":{"begin":225,"end":230},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0003062"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":225,"end":230},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A2","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}

{"project":"HP-phenotype","denotations":[{"id":"T3","span":{"begin":187,"end":192},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"HP:0002664"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"This review summarizes structural features of anti-carbohydrate antibodies to over 20 antigens, based on six categories of glyco-antigen: (i) the glycan shield of HIV glycoproteins; (ii) tumor epitopes; (iii) glycolipids and blood group A antigen; (iv) internal epitopes of bacterial lipopolysaccharides; (v) terminal epitopes on polysaccharides and oligosaccharides, including a group of antibodies to Kdo-containing Chlamydia epitopes; and (vi) linear homopolysaccharides."}